Polaris Market Research has recently published an insightful research study titled Cell & Gene Therapy Contract Research Organizations Market Size, Share, Industry Analysis Report By Type of Therapy (Gene Therapy, Cell Therapy), By Type of Manufacturing Service, By Cell and Gene Therapy Modality, By Therapeutic Area, and By End-User, By Region – Market Forecast, 2025-2034
Global Cell & Gene Therapy Contract Research Organizations Market is currently valued at USD 4.82 Billion in 2024 and is anticipated to generate an estimated revenue of USD 12.29 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 9.84% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 – 2034
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
http://www.polarismarketresearch.com/industr…for-sample
The cell and gene therapy (CGT) contract research organizations (CROs) market is growing rapidly due to increased R&D investments in personalized medicine. Rising demand for outsourcing clinical trials, manufacturing, and regulatory support drives market adoption. Technological advancements in viral vector production, cell engineering, and GMP-compliant facilities enhance CRO capabilities. North America and Europe dominate due to established biotech hubs and favorable regulations. Market players focus on scalability, cost efficiency, and quality compliance. Increasing prevalence of genetic disorders and oncology applications boosts demand. Strategic partnerships with pharmaceutical and biotech companies expand service portfolios. Regulatory complexities and specialized expertise requirements are key challenges. Overall, CGT CROs are critical enablers of next-generation therapeutic development.
The report evaluates the Cell & Gene Therapy Contract Research Organizations market size and share by conducting a thorough examination within a specific timeframe. With a focus on the market, the study delves into consumption patterns, emerging trends, and sales performance in key countries. To begin with, the report establishes the market’s concept and scope, encompassing product classifications, application areas, and the geographic coverage of the entire study.
The report features the recent and upcoming growth trends of this business and explains the regional spectrum of the market. The dynamics, such as drivers, restraints, and opportunities, have been presented with their corresponding impact analysis. The research report presents a comprehensive segmentation analysis, examining all significant segments in terms of Cell & Gene Therapy Contract Research Organizations market growth, share, growth rate, and other essential factors. Additionally, it includes an attractiveness index for each segment, enabling market players to identify the most profitable revenue opportunities within the market. This analysis provides valuable insights for businesses aiming to establish a strong market presence.
Competitive Landscape Analysis:
The report shifts its attention to the present competitive landscape within the market. It furnishes fundamental details, data, product introductions, and more pertaining to Cell & Gene Therapy Contract Research Organizations market key players. The comprehensive examination of the market’s competitive scenario will aid players in formulating innovative strategies to maintain their position in the industry. Furthermore, the report encompasses recent collaborations, mergers, acquisitions, and partnerships, along with an assessment of regulatory frameworks across various regions that influence the trajectory of the Cell & Gene Therapy Contract Research Organizations market.
Key Players:
* Altasciences
* Allucent
* CMED
* CMIC Group
* ICON plc
* Labcorp Drug Development (Labcorp)
* Linical Accelovance
* Medpace, Inc.
* Novotech CRO
* Pharmalex GmbH
* PPD (Thermo Fisher Scientific, Inc.)
* Precision for Medicine Group LLC
* QPS Holdings, LLC
* Syneos Health, Inc.
* Syngene International Limited
Cell & Gene Therapy Contract Research Organizations – Industry Developments
* April 2025: AGC Biologics launched a new cell and gene technologies division to enhance its CDMO capabilities, supporting developers facing capacity and technical challenges in advanced therapies. The division is anchored by the Milan Cell and Gene Center of Excellence, which has 30 years of experience, nine commercial product approvals, and has produced hundreds of GMP batches.
* November 2024: QPS Holdings, LLC introduced a new cell therapy business unit at its Springfield, Missouri campus, featuring a dedicated Leukopak collection and blood product processing center to meet the growing demand for raw materials essential to cell and gene therapy development.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
http://www.polarismarketresearch.com/industr…ons-market
Cell & Gene Therapy Contract Research Organizations Market Segmentation
By Type of Therapy Outlook (Revenue, USD Billion, 2020-2034)
* Gene Therapy
* Cell Therapy
* Stem Cell Therapy
* CAR-T Therapy
* Other Cell Therapies
By Type of Manufacturing Service Outlook (Revenue, USD Billion, 2020-2034)
* Development Services
* Production Services
* Other Services
By Cell and Gene Therapy Modality Outlook (Revenue, USD Billion, 2020-2034)
* Viral Vectors
* Non-Viral Vectors
* CRISPR/Cas9 and Other Gene Editing Tools
By Therapeutic Area Outlook (Revenue, USD Billion, 2020-2034)
* Oncology
* Neurology
* Cardiovascular
* Metabolic Disorders
* Other Therapeutic Areas
By End-User Outlook (Revenue, USD Billion, 2020-2034)
* Biopharmaceutical Companies
* Academic and Research Institutions
* Contract Development & Manufacturing Organizations (CDMOs)
𝐀𝐬𝐤 𝐀𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐟𝐨𝐫 𝐘𝐨𝐮𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐒𝐚𝐦𝐩𝐥𝐞:
http://www.polarismarketresearch.com/industr…tomization
Regional Analysis:
Moreover, the research offers insightful forecasts for consumption, production, sales, and other key aspects of the market. It encompasses a comprehensive analysis of major regions and countries, enabling industry players to explore untapped regional markets and formulate targeted strategies accordingly. This section also provides estimations of Cell & Gene Therapy Contract Research Organizations market share and growth rate for each region, country, and sub-region during the predicted period.
Key Regions Covered in This Report Are:
* North America (United States, Canada, and Mexico)
* Europe (Germany, France, United Kingdom, Russia, Italy, and the Rest of Europe)
* Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
* South America (Brazil, Argentina, Colombia, and the rest of South America)
* The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa, and the Rest of the Middle East and Africa)
Additionally, the report covers other crucial aspects of the market, including product definition, various applications, revenue and demand analysis, as well as supply statistics. The report’s analysts have thoroughly examined investments in research and development, the influence of changing economies, and consumer behaviors to determine the factors that will drive the overall Cell & Gene Therapy Contract Research Organizations market growth. Readers of the report will also have access to a comprehensive study on market positioning, which includes factors such as target clients, brand strategy, and price strategy.
Key Questions Answered in The Report:
Q1. Which are the top players in the market?
Ans – ICON plc, Labcorp Drug Development, Syneos Health Inc., Altasciences, PPD (Thermo Fisher Scientific), QPS Holdings LLC, AGC Biologics, Precision for Medicine Group LLC, and Novotech CRO.
Q2. How will the market change in the next years?
Ans – Market will shift toward decentralized clinical trials; increased focus on GMP-compliant manufacturing; growing adoption of CAR-T and CRISPR technologies; expansion of development services.
Q3. Which regional market will show the highest growth?
Ans – North America dominated in 2024; Europe projected for fastest growth driven by EMA’s ATMP framework and rising R&D expenditure.
Q4. What will be the CAGR and size of the market throughout the forecast period?
Ans – CAGR: 9.84% from 2025-2034; Market size: USD 4.82 billion (2024) → USD 12.29 billion (2034).
Q5. What growth opportunities does the market offer?
Ans – Opportunities in CAR-T manufacturing, CRISPR gene editing services, viral vector production, personalized medicine development, and academic research partnerships.
News From
Polaris Market Research &…
Category: Industry Reports & Market Analysis Profile: Polaris Market Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight and market intelligence to our customers across various industries. We at Polaris are obliged to serve our client base across the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, ch …
This email address is being protected from spambots. You need JavaScript enabled to view it.
